Paul Hastings LLP advised GenScript Biotech Corporation and and its subsidiary Probio Technology Limited on the deal. GenScript ProBio announced its Series C round of financing...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...
You must be a Standard 1 Year member to access this content.
Jones Day represented GenScript Biotech Corporation on the deal. Probio Technology Limited (“Probio Cayman”), led by Zhenjiang High-tech Venture Capital (HK) Limited and subsidiary of GenScript Biotech Corporation,...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised GenScript Biotech Corporatio on the deal. GenScript Biotech Corporation (HKEX Stock Code: 1548.HK) and its indirect wholly-owned subsidiary Probio Technology Limited (“Probio”) announced a Series...
You must be a Standard 1 Year member to access this content.
